ACHL, Pro-ficiency, Simumetrix and ArcheMedX were recognized for collaboration on The Evolution of Therapies for NSCLC: Navigating New Therapies & Counseling Patients in Clinical Decisions
CHARLOTTESVILLE, Va., May 2, 2018 (Newswire.com) - The Academy of Continued Healthcare Learning (ACHL), Pro-ficiency, Simumetrix and ArcheMedX have been recognized by The National Association of Medical Education Companies (NAMEC) for their innovative collaboration on The Evolution
I quickly pulled together a Storify this morning to archive all of the wonder and learning that is CMEpalooza.
Enjoy!
[View the story "CMEpalooza Spring 2017" on Storify]
SPEED, COST, and ACCESSIBILITY
What makes social media an attractive CME tool is its accessibility and low cost, not to mention the speed with which it prompts immediate interaction, notes Brian McGowan, cofounder and chief learning officer of ArcheMedX, a healthcare e-learning company. Michael Leis, SVP, social strategy at Digitas Health
Imedex, the University of Nebraska Medical Center, Center for Continuing Education and College of Nursing Continuing Nursing Education, ArcheMedX, and breast cancer survivors recognized for a unique series of online CME-certified activities
ALPHARETTA, GA (PRWEB) JANUARY 21, 2016
On January 12, 2016, Imedex, LLC, based in in Alpharetta, GA, and its collaborating
Building upon the success of two prior online CME programs, NACCME and ArcheMedX are developing a new educational curriculum that will utilize the ArcheViewer to deliver education designed to improve the assessment and treatment of patients with Psoriasis.
Charlottesville, VA (January 8, 2016) – Following the success of two highly
Millions of clinicians can now access an interactive online CME program designed to improve learning and competency around the use of Monoclonal Antibody Therapeutics in Dyslipidemia Management
Charlottesville, VA (PRWEB) May 05, 2015
ArcheMedX announced today, in collaboration with PIM and AcademicCME, the launch of an innovative continuing medical education (CME) program
BACKGROUND:
The Performance Improvement (PI) CME format improves physician performance in other specialties but data are lacking in dermatology.
OBJECTIVE:
We sought to assess the impact of a PI CME activity on physician practice patterns for patients with psoriasis, which was developed, implemented, and evaluated by the American Academy of Dermatology (AAD), in
This presentation was conducted on April 8th 2015 as part of the Spring 2015 CMEPalooza. To access the other 8th session that took place that day, please visit the CMEpalooza spring webpage.
Our Abstract:
In the formative days of continuing education (CE), when “producing” content was a specialized competency, educational planners had
Introduction:
In the formative days of continuing education (CE), when “producing” content was a specialized competency, educational planners had little choice but to develop content, package it into slides or a monograph or a video, and then sit back and hope it had the impact that was intended. But times have
First up this week in our “5 Minutes With…” series is Brian McGowan, PhD, Chief Learning Officer & Co-Founder at ArcheMedX, Inc. ArcheMedX is one of our gold-level sponsors, and they are sponsoring the lunchtime panel session Brian has put together on Data-Driven and Agile Educational Design: Ensuring Your Courses Intelligently Evolve.
Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the growing complexity in clinical trial protocols. The Director of the Tufts Center for the Study of Drug Development and a Research Professor at the Tufts University School of Medicine, Ken shares his insights
Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, to discuss best practices for sites making the shift toward decentralized trials.
Paul shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to
UpcomingEvents
Meet us at our upcoming events, or join us at a webinar.
Join us at fierce jpm week
January 18-20, 2022We'll be attending the virtual sessions of Fierce JP Morgan Week to network and discuss the challenges the life sciences industry continues to face. Book a meeting with us during the event
Predict and improve clinical trialsite and team performance.Uncover risks sooner. Eliminate delays.
Request a Demo
Meet Ready, a Smarter Way to
Accelerate Enrollment and Minimize Risks.
Ready by ArcheMedX transforms site selection and site initiation to reveal which teams and sites are best prepared to successfully conduct the most critical aspects of your
Ready Helps CROs Build
Exceptional Teams and
Win More Work.
CROs use Ready by ArcheMedX to better equip their trial teams, demonstrate team capability, and reduce study costs.
Request a Demo
Meet Ready for Clinical Research Organizations
Ready predicts and improves the performance of trial teams and sites.
Download the brochure
PROVE YOUR TEAM’S CAPABILITIES
Demonstrate the expertise
Sponsors Should Expect Better Teams, Better Sites, and Better Trials.
With Ready by ArcheMedX, uncover risks sooner and upskill your clinical trial team to eliminate study delays.
Request a Demo
Meet Ready for Clinical Trial Sponsors
The clinical trials learning platform that helps you predict and improve study performance.
PRIORITIZE ACTIVATION, ACCELERATE ENROLLMENT, MITIGATE
Predict and improve clinical trial
site and team performance.
Uncover risks. Eliminate delays.
Request a Demo
Ready Helps CROs Build
Exceptional Teams and
Win More Work.
CROs use Ready by ArcheMedX to better equip their trial teams, demonstrate team capability, and reduce study costs.
Request a Demo
Ready Helps CROs Build
Exceptional Teams and
Win More Work.
CROs use Ready
Are you At Risk?Introducing Ready, a smarter way to predict and improve clinical trial team performance.
Learn More
A faster way to prepare sites, teams, and clinicians.
A more effective way to validate their readiness.
Clinical Operations
Predict and improve how sites and teams will perform in your clinical trial. Identify risks sooner and tailor
